{"id":22111,"date":"2025-02-12T22:55:38","date_gmt":"2025-02-12T23:55:38","guid":{"rendered":"https:\/\/medexperts.pro\/?p=22111"},"modified":"2025-02-13T00:24:58","modified_gmt":"2025-02-13T00:24:58","slug":"openai-questions-rationale-of-elon-musks-bid-to-control-the-company","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=22111","title":{"rendered":"OpenAI Questions Rationale of Elon Musk\u2019s Bid to Control the Company"},"content":{"rendered":"
<\/div>\n

The company answered the billionaire\u2019s offer in a legal filing, accusing him of hypocrisy.<\/p>\n

\n
\n
\n

OpenAI\u2019s board of directors on Wednesday questioned the rationale of a $97.4 billion bid from Elon Musk and others to gain control of the high-profile artificial intelligence company.<\/p>\n

On Monday, a consortium of investors led by Mr. Musk offered to buy<\/a> the assets of the nonprofit that controls the company, escalating a yearslong feud between Mr. Musk and OpenAI\u2019s chief executive, Sam Altman.<\/p>\n

In a court filing on Wednesday, the company said Mr. Musk\u2019s bid contradicted legal claims the billionaire made in a lawsuit he brought against OpenAI last year. OpenAI argued in its filing that Mr. Musk said in his lawsuit the assets must remain with the nonprofit and could not be transferred to another entity for public gain.<\/p>\n

The company is essentially accusing Mr. Musk of hypocrisy. In his lawsuit, he argued OpenAI must be governed by the nonprofit. Now, OpenAI contends, he is arguing the opposite.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

The OpenAI board has not yet formally rejected the bid.<\/p>\n

Marc Toberoff, a Los Angeles lawyer who filed the lawsuit against OpenAI on behalf of Mr. Musk, said in a statement to The New York Times on Wednesday: \u201cThe lawsuit is not about who controls OpenAI. It\u2019s about Sam Altman and OpenAI\u2019s misconduct.\u201d<\/p>\n

If OpenAI\u2019s board \u201cis prepared to stipulate to take the \u2018For Sale\u2019 sign off the charity\u2019s assets in its so-called \u2018conversion,\u2019 Musk will withdraw his bid,\u201d Mr. Toberoff added, referring to OpenAI\u2019s efforts to sever itself from the nonprofit\u2019s control. \u201cBut, of course, OpenAI will never do that.\u201d<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

The company answered the billionaire\u2019s offer in a legal filing, accusing him of hypocrisy.OpenAI\u2019s board of directors on Wednesday questioned the rationale of a $97.4 billion bid from Elon Musk and others to gain control of the high-profile artificial intelligence company.On Monday, a consortium of investors led by Mr. Musk offered to buy the assets of the nonprofit that controls the company, escalating a yearslong feud between Mr. Musk and OpenAI\u2019s chief executive, Sam Altman.In a court filing on Wednesday, the company said Mr. Musk\u2019s bid contradicted legal claims the billionaire made in a lawsuit he brought against OpenAI last year. OpenAI argued in its filing that Mr. Musk said in his lawsuit the assets must remain with the nonprofit and could not be transferred to another entity for public gain.The company is essentially accusing Mr. Musk of hypocrisy. In his lawsuit, he argued OpenAI must be governed by the nonprofit. Now, OpenAI contends, he is arguing the opposite.The OpenAI board has not yet formally rejected the bid.Marc Toberoff, a Los Angeles lawyer who filed the lawsuit against OpenAI on behalf of Mr. Musk, said in a statement to The New York Times on Wednesday: \u201cThe lawsuit is not about who controls OpenAI. It\u2019s about Sam Altman and OpenAI\u2019s misconduct.\u201dIf OpenAI\u2019s board \u201cis prepared to stipulate to take the \u2018For Sale\u2019 sign off the charity\u2019s assets in its so-called \u2018conversion,\u2019 Musk will withdraw his bid,\u201d Mr. Toberoff added, referring to OpenAI\u2019s efforts to sever itself from the nonprofit\u2019s control. \u201cBut, of course, OpenAI will never do that.\u201dWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":22113,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-22111","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/22111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22111"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/22111\/revisions"}],"predecessor-version":[{"id":22114,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/22111\/revisions\/22114"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/22113"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}